{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:04:25Z","timestamp":1792800265182,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Neurological Disease and Stroke","award":["R01NS105845-01"],"award-info":[{"award-number":["R01NS105845-01"]}],"id":[{"id":"https:\/\/ror.org\/05ghs6f64","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"crossref","award":["1 U54 NS092090-01"],"award-info":[{"award-number":["1 U54 NS092090-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["MH002961-02"],"award-info":[{"award-number":["MH002961-02"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Phelan-McDermid syndrome (PMS) is a genetic condition characterized by intellectual disability, speech and language deficits, hypotonia, autism spectrum disorder, and epilepsy. PMS is caused by 22q13.33 deletions or mutations affecting\n                      <jats:italic>SHANK3<\/jats:italic>\n                      , which codes for a critical scaffolding protein in excitatory synapses.\n                      <jats:italic>SHANK3<\/jats:italic>\n                      variants are also known to be associated with an increased risk for regression, as well as for psychiatric disorders, including bipolar disorder and catatonia. This study aimed to further describe these phenomena in PMS and to explore any relationship between psychiatric illness and regression after early childhood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-eight people with PMS were recruited to this study through the Phelan-McDermid Syndrome Foundation based on caregiver report of distinct development of psychiatric symptoms. Caregivers completed a clinician-administered semi-structured interview focused on eliciting psychiatric symptomatology. Data from the PMS International Registry were used to confirm genetic diagnoses of participants and to provide a larger sample for comparison.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age of the 38 participants was 24.7\u2009years (range\u2009=\u200913 to 50; SD\u2009=\u200910.06). Females (31 of 38 cases; 82%) and sequence variants (15 of 38 cases; 39%) were over-represented in this sample, compared to base rates in the PMS International\u00a0Registry. Onset of psychiatric symptoms occurred at a mean age of 15.4\u2009years (range\u2009=\u20097 to 32), with presentations marked by prominent disturbances of mood. Enduring substantial loss of functional skills after onset of psychiatric changes was seen in 25 cases (66%). Symptomst indicative of catatonia occurred in 20 cases (53%). Triggers included infections, changes in hormonal status, and stressful life events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study confirms that individuals with PMS are at risk of developing severe neuropsychiatric illness in adolescence or early adulthood, including bipolar disorder, catatonia, and lasting regression of skills. These findings should increase the awareness of these phenotypes and lead to earlier diagnosis and the implementation of appropriate interventions. Our findings also highlight the importance of genetic testing in the work-up of individuals with intellectual disability and acute psychiatric illness or regression. Future research is needed to clarify the prevalence and nature of psychiatric disorders and regression among larger unbiased samples of individuals with PMS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11689-020-9309-6","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T06:03:27Z","timestamp":1581487407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Psychiatric illness and regression in individuals with Phelan-McDermid syndrome"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-9542","authenticated-orcid":false,"given":"Teresa M.","family":"Kohlenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Pilar","family":"Trelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"McLarney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Betancur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Thurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kolevzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"9309_CR1","volume-title":"Gene Reviews","author":"K Phelan","year":"1993","unstructured":"Phelan K, Rogers RC, Boccuto L. Phelan-McDermid syndrome. In: Adam M, Ardinger H, Pagon R, Wallace S, Bean L, Stephens K, editors. Gene Reviews. Seattle: University of Washington; 1993."},{"key":"9309_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/2040-2392-5-30","volume":"5","author":"X Wang","year":"2014","unstructured":"Wang X, Xu Q, Bey AL, Lee Y, Jiang YH. Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice. Mol Autism. 2014;5:30.","journal-title":"Mol Autism."},{"key":"9309_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neubiorev.2016.01.001","volume":"63","author":"J Costales","year":"2016","unstructured":"Costales J, Kolevzon A. The therapeutic potential of insulin-like growth Factor-1 in central nervous system disorders. Neurosci Biobehav Rev. 2016;63:207\u201322. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.01.001.","journal-title":"Neurosci Biobehav Rev"},{"key":"9309_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jmg.40.8.575","volume":"40","author":"H Wilson","year":"2003","unstructured":"Wilson H, Wong A, Shaw S, Tse W, Stapleton G, Phelan MC, et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3\/PROSAP2 in the major neurological symptoms. J Med Genet. 2003;40:575\u201384.","journal-title":"J Med Genet"},{"issue":"1","key":"9309_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng1933","volume":"39","author":"CM Durand","year":"2007","unstructured":"Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 2007;39(1):25\u20137.","journal-title":"Nat Genet"},{"issue":"7","key":"9309_CR6","doi-asserted-by":"publisher","first-page":"e1002173","DOI":"10.1371\/journal.pgen.1002173","volume":"7","author":"Maria Clara Bonaglia","year":"2011","unstructured":"Bonaglia MC, Giorda R, Beri S, de Agostini C, Novara F, Fichera M, et al. Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with phelan\/mcdermid syndrome. PLoS Genet. 2011;7(7):e1002173.","journal-title":"PLoS Genetics"},{"issue":"1","key":"9309_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-018-0205-9","volume":"9","author":"S De Rubeis","year":"2018","unstructured":"De Rubeis S, Siper PM, Durkin A, Weissman J, Muratet F, Halpern D, et al. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations. Mol Autism. 2018;9(1):1\u201320.","journal-title":"Mol Autism"},{"issue":"7","key":"9309_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00439-014-1423-7","volume":"133","author":"SM Sarasua","year":"2014","unstructured":"Sarasua SM, Boccuto L, Sharp JL, Dwivedi A, Chen CF, Rollins JD, et al. Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome. Hum Genet. 2014;133(7):847\u201359. [cited 2015 Jan 12]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24481935","journal-title":"Hum Genet"},{"issue":"1","key":"9309_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2040-2392-4-18","volume":"4","author":"L Soorya","year":"2013","unstructured":"Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, Schwartz L, et al. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Mol Autism. 2013;4(1):18. [cited 2015 Jan 12]; Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3707861&tool=pmcentrez&rendertype=abstract","journal-title":"Mol Autism"},{"key":"9309_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1866-1955-6-39","volume":"6","author":"A Kolevzon","year":"2014","unstructured":"Kolevzon A, Angarita B, Bush L, Wang AT, Frank Y, Yang A, et al. Phelan-McDermid syndrome : a review of the literature and practice parameters for medical assessment and monitoring. J Neurodev Disord. 2014;6:39.","journal-title":"J Neurodev Disord"},{"key":"9309_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.yebeh.2017.11.034","volume":"80","author":"O Khan","year":"2018","unstructured":"Khan O, Zhou X, Leon J, Kessler R, Gaughan T, D\u2019Souza P, et al. Prospective longitudinal overnight video-EEG evaluation in Phelan-McDermid Syndrome. Epilepsy Behav. 2018;80:312\u201320.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"9309_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ajmg.a.30780","volume":"137","author":"AR Jeffries","year":"2005","unstructured":"Jeffries AR, Curran S, Elmslie F, Sharma A, Wenger S, Hummel M, et al. Molecular and phenotypic characterization of ring chromosome 22. Am J Med Genet A. 2005;137(2):139\u201347. [cited 2015 Jan 12]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16059935","journal-title":"Am J Med Genet A"},{"issue":"3","key":"9309_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajmg.a.33253","volume":"152","author":"SU Dhar","year":"2010","unstructured":"Dhar SU, Del Gaudio D, German JR, Peters SU, Ou Z, Bader PI, et al. 22q13.3 Deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet Part A. 2010;152(3):573\u201381. [cited 2015 Jan 12]; Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3119894&tool=pmcentrez&rendertype=abstract","journal-title":"Am J Med Genet Part A"},{"issue":"10","key":"9309_CR14","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/epi.13506","volume":"57","author":"JL Holder","year":"2016","unstructured":"Holder JL, Quach MM. The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss of function mutations. Epilepsia. 2016;57(10):1651\u20139.","journal-title":"Epilepsia"},{"issue":"1","key":"9309_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12888-015-0490-1","volume":"15","author":"S Serret","year":"2015","unstructured":"Serret S, Th\u00fcmmler S, Dor E, Vesperini S, Santos A, Askenazy F. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports. BMC Psychiatry. 2015;15(1):107. Available from: http:\/\/www.biomedcentral.com\/1471-244X\/15\/107%5Cnhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25947967%5Cnhttp:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC4428105","journal-title":"BMC Psychiatry"},{"issue":"1","key":"9309_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000339119","volume":"3","author":"A Denayer","year":"2012","unstructured":"Denayer A, Van Esch H, De Ravel T, Frijns JP, Van Buggenhout G, Vogels A, et al. Neuropsychopathology in 7 patients with the 22q13 deletion syndrome: Presence of bipolar disorder and progressive loss of skills. Mol Syndromol. 2012;3(1):14\u201320. [cited 2015 Jan 12]. https:\/\/doi.org\/10.1159\/000339119.","journal-title":"Mol Syndromol"},{"issue":"1","key":"9309_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/ajmg.a.35597","volume":"161A","author":"WMA Verhoeven","year":"2013","unstructured":"Verhoeven WMA, Egger JIM, Cohen-Snuijf R, Kant SG, de Leeuw N. Phelan-McDermid syndrome: clinical report of a 70-year-old woman. Am J Med Genet A. 2013;161A(1):158\u201361. [cited 2015 Jan 12]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23166010","journal-title":"Am J Med Genet A"},{"issue":"11","key":"9309_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ejmg.2012.07.009","volume":"55","author":"K Vucurovic","year":"2012","unstructured":"Vucurovic K, Landais E, Delahaigue C, Eutrope J, Schneider A, Leroy C, et al. Bipolar affective disorder and early dementia onset in a male patient with SHANK3 deletion. Eur J Med Genet. 2012;55(11):625\u20139. [cited 2015 Jan 12]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22922660","journal-title":"Eur J Med Genet"},{"key":"9309_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/gbb.12285","volume":"15","author":"JIM Egger","year":"2016","unstructured":"Egger JIM, Zwanenburg RJ, Van Ravenswaaij-Arts CMA, Kleefstra T, Verhoeven WMA. Neuropsychological phenotype and psychopathology in seven adult patients with Phelan-McDermid syndrome: implications for treatment strategy. Genes Brain Behav. 2016;15:395\u2013404.","journal-title":"Genes Brain Behav"},{"key":"9309_CR20","doi-asserted-by":"publisher","unstructured":"Verhoeven WMA, Egger JIM, de Leeuw N. A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome. Eur J Med Genet. 2019:103751. https:\/\/doi.org\/10.1016\/j.ejmg.2019.103751.","DOI":"10.1016\/j.ejmg.2019.103751"},{"key":"9309_CR21","doi-asserted-by":"publisher","first-page":"7863","DOI":"10.1073\/pnas.0906232107","volume":"107","author":"J Gauthier","year":"2010","unstructured":"Gauthier J, Champagne N, Lafreni\u00e8re RG, Xiong L, Spiegelman D, Brustein E, et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci. 2010;107:7863\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"9309_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ejmg.2016.08.003","volume":"59","author":"J Breckpot","year":"2016","unstructured":"Breckpot J, Vercruyssen M, Weyts E, Vandevoort S, D\u2019Haenens G, Van Buggenhout G, et al. Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor. Eur J Med Genet. 2016;59:436\u201343.","journal-title":"Eur J Med Genet"},{"issue":"4","key":"9309_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/13554794.2018.1542007","volume":"24","author":"P Jungov\u00e1","year":"2018","unstructured":"Jungov\u00e1 P, \u010cumov\u00e1 A, Kramarov\u00e1 V, Lisyov\u00e1 J, \u010eurina P, Chandoga J, et al. Phelan-McDermid syndrome in adult patient with atypical bipolar psychosis repeatedly triggered by febrility. Neurocase. 2018;24(4):227\u201330. https:\/\/doi.org\/10.1080\/13554794.2018.1542007.","journal-title":"Neurocase"},{"key":"9309_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.schres.2016.06.020","volume":"176","author":"X Benarous","year":"2016","unstructured":"Benarous X, Consoli A, Raffin M, Bodeau N, Giannitelli M, Cohen D, et al. Validation of the Pediatric Catatonia Rating Scale (PCRS). Schizophr Res. 2016;176:378\u201386.","journal-title":"Schizophr Res"},{"key":"9309_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.pediatrneurol.2010.07.001","volume":"43","author":"DM Dhossche","year":"2010","unstructured":"Dhossche DM, Wachtel LE. Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol. 2010;43:307\u201315.","journal-title":"Pediatr Neurol"},{"key":"9309_CR26","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1080\/13854046.2017.1413211","volume":"32","author":"L Soorya","year":"2018","unstructured":"Soorya L, Leon J, Trelles MP, Thurm A. Framework for assessing individuals with rare genetic disorders associated with profound intellectual and multiple disabilities (PIMD): the example of Phelan McDermid syndrome. Clin Neuropsychol. 2018;32:1226\u201355.","journal-title":"Clin Neuropsychol"},{"key":"9309_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s11689-017-9217-6","volume":"9","author":"C Richards","year":"2017","unstructured":"Richards C, Powis L, Moss J, Stinton C, Nelson L, Oliver C. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder. J Neurodev Disord. 2017;9:37.","journal-title":"J Neurodev Disord"},{"key":"9309_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s11689-016-9150-0","volume":"8","author":"RJ Zwanenburg","year":"2016","unstructured":"Zwanenburg RJ, Ruiter SAJ, Van Den Heuvel ER, Flapper BCT, Van Ravenswaaij-Arts CMA. Developmental phenotype in Phelan- McDermid (22q13.3 deletion) syndrome: a systematic and prospective study in 34 children. J Neurodev Disord. 2016;8:16.","journal-title":"J Neurodev Disord"},{"key":"9309_CR29","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington:. American Journal of Psychiatry. 2013. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA:"},{"key":"9309_CR30","unstructured":"Fletcher RJ, National Association for the Dually Diagnosed., & American Psychiatric Association. DM-ID: Diagnostic Manual Intellectual Disability : a clinical guide for diagnosis of mental disorders in persons with intellectual disability. Kingston: National Association for the Dually Diagnosed; 2007."},{"key":"9309_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19315864.2016.1185324","volume":"9","author":"RJ Fletcher","year":"2016","unstructured":"Fletcher RJ, Barnhill J, McCarthy J, Strydom A. From DSM to DM-ID. J Ment Health Res Intellect Disabil. 2016;9:189\u2013204.","journal-title":"J Ment Health Res Intellect Disabil"},{"key":"9309_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s11689-015-9101-1","volume":"7","author":"EM Dykens","year":"2015","unstructured":"Dykens EM, Shah B, Davis B, Baker C, Fife T, Fitzpatrick J. Psychiatric disorders in adolescents and young adults with Down syndrome and other intellectual disabilities. J Neurodev Disord. 2015;7:9.","journal-title":"J Neurodev Disord"},{"key":"9309_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10803-017-3384-x","volume":"48","author":"F Valdes","year":"2018","unstructured":"Valdes F, Keary CJ, Mullett JE, Palumbo ML, Waxler JL, Pober BR, et al. Brief report: major depressive disorder with psychotic features in Williams syndrome: a case series. J Autism Dev Disord. 2018;48:947\u201352.","journal-title":"J Autism Dev Disord"},{"key":"9309_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","volume":"171","author":"M Schneider","year":"2014","unstructured":"Schneider M, Debban\u00e9 M, Bassett AS, Chow EWC, Fung WLA, Van Den Bree MBM, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the international consortium on brain and behavior in 22q11.2 deletion syndrome. Am J Psychiatry. 2014;171:627\u201339.","journal-title":"Am J Psychiatry"},{"key":"9309_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0074-7742(05)72014-6","volume":"72","author":"M Fink","year":"2006","unstructured":"Fink M, Taylor MA, Ghaziuddin N. Catatonia in autistic spectrum disorders: a medical treatment algorithm. Int Rev Neurobiol. 2006;72:233\u201344.","journal-title":"Int Rev Neurobiol"},{"key":"9309_CR36","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/ajmg.a.38708","volume":"176","author":"NJ Butcher","year":"2018","unstructured":"Butcher NJ, Boot E, Lang AE, Andrade D, Vorstman J, McDonald-McGinn D, et al. Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: an overview and case series. Am J Med Genet Part A. 2018;176:2146\u201359.","journal-title":"Am J Med Genet Part A"},{"key":"9309_CR37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10803-012-1621-x","volume":"43","author":"BD Barger","year":"2013","unstructured":"Barger BD, Campbell JM, McDonough JD. Prevalence and onset of regression within autism spectrum disorders: a meta-analytic review. J Autism Dev Disord. 2013;43:817\u201328.","journal-title":"J Autism Dev Disord"},{"key":"9309_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/aur.1903","volume":"11","author":"A Thurm","year":"2018","unstructured":"Thurm A, Powell EM, Neul JL, Wagner A, Zwaigenbaum L. Loss of skills and onset patterns in neurodevelopmental disorders: understanding the neurobiological mechanisms. Autism Res. 2018;11:212\u201322.","journal-title":"Autism Res"},{"issue":"4","key":"9309_CR39","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s10803-016-3004-1","volume":"47","author":"KD Gadow","year":"2017","unstructured":"Gadow KD, Perlman G, Weber RJ. Parent-reported developmental regression in autism: epilepsy, IQ, schizophrenia Spectrum symptoms, and special education. J Autism Dev Disord. 2017;47(4):918\u201326.","journal-title":"J Autism Dev Disord"},{"key":"9309_CR40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neubiorev.2019.01.028","volume":"98","author":"C Einspieler","year":"2019","unstructured":"Einspieler C, Marschik PB. Regression in Rett syndrome: developmental pathways to its onset. Neurosci Biobehav Rev. 2019;98:320\u201332.","journal-title":"Neurosci Biobehav Rev"},{"key":"9309_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpsychires.2017.03.010","volume":"91","author":"G Reierson","year":"2017","unstructured":"Reierson G, Bernstein J, Froehlich-Santino W, Urban A, Purmann C, Berquist S, et al. Characterizing regression in Phelan McDermid syndrome (22q13 deletion syndrome). J Psychiatr Res. 2017;91:139\u201344.","journal-title":"J Psychiatr Res"},{"key":"9309_CR42","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1177\/0883073814554654","volume":"30","author":"G Worley","year":"2015","unstructured":"Worley G, Crissman BG, Cadogan E, Milleson C, Adkins DW, Kishnani PS. Down syndrome disintegrative disorder: new-onset autistic regression, dementia, and insomnia in older children and adolescents with down syndrome. J Child Neurol. 2015;30:1147\u201352.","journal-title":"J Child Neurol"},{"key":"9309_CR43","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2147\/NDT.S77307","volume":"11","author":"N Ghaziuddin","year":"2015","unstructured":"Ghaziuddin N, Nassiri A, Miles JH. Catatonia in Down syndrome; a treatable cause of regression. Neuropsychiatr Dis Treat. 2015;11:941.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9309_CR44","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/dmcn.14127","volume":"61","author":"KM Cardinale","year":"2018","unstructured":"Cardinale KM, Bocharnikov A, Hart SJ, Baker JA, Eckstein C, Jasien JM, et al. Immunotherapy in selected patients with Down syndrome disintegrative disorder. Dev Med Child Neurol. 2018;61:847\u201351.","journal-title":"Dev Med Child Neurol"},{"key":"9309_CR45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3233\/JAD-170720","volume":"61","author":"PJ Lao","year":"2017","unstructured":"Lao PJ, Handen BL, Betthauser TJ, Mihaila I, Hartley SL, Cohen AD, et al. Alzheimer-like pattern of hypometabolism emerges with elevated amyloid-\u03b2 Burden in Down syndrome. J Alzheimers Dis. 2017;61:631\u201344.","journal-title":"J Alzheimers Dis"},{"key":"9309_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2017.05.019","volume":"58","author":"Sigan L. Hartley","year":"2017","unstructured":"Hartley SL, Handen BL, Devenny D, Mihaila I, Hardison R, Lao PJ, et al. Cognitive decline and brain amyloid-\u03b2 accumulation across 3 years in adults with Down syndrome. Neurobiol Aging. 2017;58:68\u201376.","journal-title":"Neurobiology of Aging"},{"key":"9309_CR47","doi-asserted-by":"crossref","unstructured":"Startin CM, Ashton NJ, Hamburg S, Hithersay R, Wiseman FK, Mok KY, et al. Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11(1):1\u201312.","DOI":"10.1186\/s13195-019-0477-0"},{"key":"9309_CR48","doi-asserted-by":"publisher","unstructured":"Kolevzon, A., Delaby, E., Berry-Kravis, E. et al. Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature. Molecular Autism. 2019: https:\/\/doi.org\/10.1186\/s13229-019-029-3.","DOI":"10.1186\/s13229-019-029-3"},{"key":"9309_CR49","doi-asserted-by":"publisher","first-page":"e903","DOI":"10.1542\/peds.2014-1839","volume":"134","author":"JB Moeschler","year":"2014","unstructured":"Moeschler JB, Shevell M. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134:e903\u201318.","journal-title":"Pediatrics"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-020-9309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s11689-020-9309-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-020-9309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T07:21:46Z","timestamp":1613028106000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-020-9309-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9309"],"URL":"https:\/\/doi.org\/10.1186\/s11689-020-9309-6","relation":{},"ISSN":["1866-1947","1866-1955"],"issn-type":[{"value":"1866-1947","type":"print"},{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,12]]},"assertion":[{"value":"31 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained for participants, who were enrolled in the Phelan-McDermid Syndrome International Registry (\n                      \n                      ).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants signed a release for publication of results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AK receives research support from AMO Pharma and consults to Ovid Therapeutics, Takeda, 5\u2009AM Ventures, sema4, and LabCorp. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}